載入...
Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who were naive to anticholinergics before the TIOtropium Safety and Performance In Respimat (TIOSPIR) trial may reflect patients seen in practice, in particular in primary care. In addition, investigating safety in these patients...
Na minha lista:
| 發表在: | NPJ Prim Care Respir Med |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634206/ https://ncbi.nlm.nih.gov/pubmed/26540491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjpcrm.2015.67 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|